Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?

J Rheumatol. 2007 Feb;34(2):438-9.
No abstract available

MeSH terms

  • Administration, Topical
  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis / complications
  • Arthritis / drug therapy
  • Drug Eruptions
  • Etanercept
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulin G / adverse effects*
  • Infliximab
  • Psoriasis / chemically induced*
  • Psoriasis / drug therapy
  • Psoriasis / pathology
  • Receptors, Tumor Necrosis Factor
  • Skin Tests
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Withholding Treatment

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Glucocorticoids
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept